Table 2.
Study | CKDu definition | Control group definition | Biomarker(s) studied | Biomarker concentration |
eGFR (ml/min per 1.73 m2) |
||
---|---|---|---|---|---|---|---|
CKDu | Control | CKDu | Control | ||||
De Silva. PLOS Negl Trop Dis, 201629 | Two values of UACR ≥30 mg/g in the absence of prior glomerular disease, pyelonephritis, nephrolithiasis, snake bite, diabetes, HbA1c >6.5%, or HTN (N = 14)a | Residence in a nonendemic area (N = 54)a | KIM-1 (μg/g) | 64 ± 11 | 1.3 ± 0.2 | 96.5 ± 4.5 | 110.0 ± 2.6 |
NGAL (ug/g) | 2 ± 0.6 | 0.3 ± 0.03 | |||||
Ekanayake. Int J Environ Res Publ Health, 202232 | Clinically diagnosed with CKDu (N = 40) | Factory workers from CKDu-endemic regions (N = 33)b | KIM-1 (ng/mg) | 5 [4–9] | 2 [0.5–2] | 20.0 [9.9–34.8] | 115.1 [108.4–131.3] |
NGAL (ng/mg) | 22 [4–154] | 2 [0.7-5] | |||||
Fernando. KIR, 201930 | Biopsy features consistent with CKDu from individuals living in a CKDu-endemic area for ≥ 5 years. Other causes of CKD were excluded by clinical judgment (N = 75) | Age- and sex-matched residents of nonendemic regions with no evidence of kidney disease (N = 85) | A1M (ng/g) | 870 [6473] | 54 [58.4] | Not reported | Not reported |
B2M (ng/g) | 383 [1519] | 48 [70] | 42.7% with eGFR > 60 | 98.8% with eGFR > 60 | |||
Cystatin c (ng/g) | 4 [17] | 1 [1] | |||||
NGAL (ng/g) | 20 [35] | 3 [6] | |||||
OPN (ng/g) | 68 [99] | 50 [40] | |||||
RBP4 (ng/g) | 478 [551] | 188 [200] | |||||
KIM-1 (ng/g) | 0.05 [0.08] | 0.05 [0.06] | |||||
TIMP-1 (ng/g) | 0.6 [1] | 0.4 [0.8] | |||||
Nanayakkara. Environ Health Prev Med, 201263 | CKDu previously diagnosed through a screening program (N = 106) | Apparently healthy adults from the general population of Kyoto, Japan (N = 50)c | A1M (mg/g) | Overall sample mean not reportedd | GM 0.6 ± 6 | Not reported | Not reported |
NAG (U/g) | Overall sample mean not reported | GM 0.9 ± 4 | 28% with eGFR >60 | ||||
Wanigasuriya. Ceylon Med J, 201748 | Fulfilled the diagnostic criteria for suspected CKDu and had a SCr ≥2 mg/dl (N = 37) | Nonfarmer residents of a nonendemic area (N = 40)e | Fibrinogen (ng/mg) | 20 [9–134] | 6 [4–8] | 23.5 ± 1.2 | 76.1 ± 8.3 |
B2M (ng/mg) | 4643 [249–15375] | 118 [44–181] | |||||
Clusterin (ng/mg) | 372 [222–1587] | 836 [366–1525] | |||||
KIM-1 (pg/mg) | 505 [346–1008] | 403 [311–672] | |||||
Cystatin c (ng/mg) | 681 [43–3650] | 243 [96–362] | |||||
Siriwardhana. BMC Nephrol, 201460 | Diagnosed as having CKDu by a nephrologist. Known causes of CKD (e.g., glomerular disease, diabetes, longstanding HTN, snake bite, leptospirosis, congenital kidney disease, nephrolithiasis) were excluded by clinical judgment. (N = 30) | Age-matched and sex-matched residents of the same area; SCr <1.0 mg/dl, random glucose <140 mg/dl, blood pressure <120/80, and negative proteinuria (N = 30) | B2M (μg/ml) | 1.24 ± 0.71 | 0.16 ± 0.05 | Not reported | Not reported |
A1M, alpha-1-microglobulin; B2M, beta-2-microglobulin; CKDu, chronic kidney disease of uncertain etiology; eGFR, estimated glomerular filtration rate; GM, geometric mean; HbA1c, hemoglobin A1c; HTN, hypertension; KIM-1, kidney injury molecule 1; NAG, N-acetyl-beta-D-glucosaminidase; NGAL, neutrophil gelatinase-associated lipocalin; RBP-4, retinol binding protein 4; SCr, serum creatinine; TIMP1, tissue inhibitor matrix metalloproteinase 1; UACR, urinary albumin-to-creatinine ratio.
Not all studies in the table employed a traditional case-control design. In some instances, case-control status was determined after receiving the test results of population-wide screening programs.
Values are reported as mean ± SD or median [interquartile range].
This study evaluated participants from 2 endemic and 2 nonendemic regions separately. Data are presented for 1 of the 2 groups for simplicity.
This study included multiple occupational groups. Factory workers were selected as the representative control as they were the only nonagricultural occupation.
This study also included healthy, nonaffected relatives as a control group, which is not presented in the table for simplicity.
This study provided mean biomarker concentration stratified by eGFR category only for those participants identified as having CKDu.
This study also included a sample of farmer controls, which are not presented in the table for simplicity.